Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Academic Discovery Workshop

23 Sep 2014 - 25 Sep 2014 - Baltimore, MD, USA



Bookmark and Share


The drug discovery landscape is facing many challenges and changes fueled in part with the ongoing de-risking efforts by the Pharma industry; seemingly downsizing their footprint or exiting the space all together. The emerging new paradigm seems to be revolving around academic and non-for-profit institutions to carry out the discovery part of the process across a multitude of therapeutic areas. What has started as a successful interactive workshop for academic screening for the past three years, has now evolved to encompass all discovery aspects from technology development, hit identification, to licensing deals.

This new format will continue to provide delegates the opportunity to learn as well as share experiences about enabling technologies, hit to lead generation, dealing with academic tech transfer offices, identifying and working with CROs, and interrogating the value proposition of functional genomics in translational research. Organised by Dr Hakim Djaballah, Director of the HTS Core Facility at Memorial Sloan Kettering Cancer Center, our 4th Annual Academic Discovery Workshop will take place at the Sheraton Baltimore North in Baltimore from September 23rd-25th. Whether delegates are looking to expand their knowledge, engage in discussions with thought leaders during the afternoon panel discussion sessions, or simply requiring more of an insight to aid and foster future collaborations, this workshop together with the newly established short courses is highly recommended to anyone working or has an interest in drug discovery from academia, research institutes, biotech, and Pharma companies.

The workshop also aims to help energize the discovery paradigm through open panel discussions on highly provocative topics such as “Target-based versus phenotypic-based drug discovery”, “Functional genomics technologies and their impact of target identification”, or "private-public partnerships". it is hoped that through these kind of open discussions, delegates will have the opportunity to build their own consensus and bring their points of view across. We are always seeking new ideas and inputs to help discover novel or repurpose known drugs to fight disease whether in a pharmaceutical or academic setting.

Agenda Topics:

  • Academic Technology Transfer: Due Diligence, Development and Commercialisation
  • Building and Financing Drug Discovery Efforts in Academia
  • Functional Genomics Technologies in 2014
  • Identifying and Working with CRO's
  • Novel and Enabling Screening Technologies in 2014
  • Public - Private Partnerships
  • RNAi and Genome Editing Technologies
  • Target versus Phenotypic Based Discovery
  • Vendor/User Perspectives on HCA in 2014




Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!